DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Lobeline is an investigational drug.
There have been 5 clinical trials for Lobeline. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2017.
The most common disease conditions in clinical trials are Neoplasm Metastasis, Attention Deficit Disorder with Hyperactivity, and Amphetamine-Related Disorders. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Haining Health-Coming Biotech Co., Ltd., and Yaupon Therapeutics.
Recent Clinical Trials for Lobeline
|Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor||Haining Health-Coming Biotech Co., Ltd.||Phase 2|
|Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients||National Institute of Mental Health (NIMH)||Phase 2|
|Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients||Yaupon Therapeutics||Phase 2|